These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 32381118)

  • 1. Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives.
    Cheng Y; Tian DY; Wang YJ
    Transl Neurodegener; 2020 May; 9(1):16. PubMed ID: 32381118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease.
    Li Y; Zhang J; Wan J; Liu A; Sun J
    Biomed Pharmacother; 2020 Dec; 132():110887. PubMed ID: 33254429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease.
    Xiang Y; Bu XL; Liu YH; Zhu C; Shen LL; Jiao SS; Zhu XY; Giunta B; Tan J; Song WH; Zhou HD; Zhou XF; Wang YJ
    Acta Neuropathol; 2015 Oct; 130(4):487-99. PubMed ID: 26363791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.
    Xin SH; Tan L; Cao X; Yu JT; Tan L
    Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trajectory of brain-derived amyloid beta in Alzheimer's disease: where is it coming from and where is it going?
    Liu N; Haziyihan A; Zhao W; Chen Y; Chao H
    Transl Neurodegener; 2024 Aug; 13(1):42. PubMed ID: 39160618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer's disease.
    Zhang X; O'Callaghan P; Li H; Tan Y; Zhang G; Barash U; Wang X; Lannfelt L; Vlodavsky I; Lindahl U; Li JP
    Acta Neuropathol Commun; 2021 May; 9(1):84. PubMed ID: 33971986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroacupuncture Improves Clearance of Amyloid-
    Liang PZ; Li L; Zhang YN; Shen Y; Zhang LL; Zhou J; Wang ZJ; Wang S; Yang S
    Neural Plast; 2021; 2021():9960304. PubMed ID: 34484327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease.
    Uddin MS; Kabir MT; Tewari D; Mamun AA; Mathew B; Aleya L; Barreto GE; Bin-Jumah MN; Abdel-Daim MM; Ashraf GM
    J Neurol Sci; 2020 Sep; 416():116974. PubMed ID: 32559516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connections Between Amyloid Beta and the Meningeal Lymphatics As a Possible Route for Clearance and Therapeutics.
    Dupont G; Iwanaga J; Yilmaz E; Tubbs RS
    Lymphat Res Biol; 2020 Feb; 18(1):2-6. PubMed ID: 31433264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems.
    Loeffler DA
    J Alzheimers Dis; 2024; 100(2):379-411. PubMed ID: 38875041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis and Therapeutic Strategies in Alzheimer's Disease: From Brain to Periphery.
    Yu JT; Zhang C
    Neurotox Res; 2016 Feb; 29(2):197-200. PubMed ID: 26597964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of dural sinus-associated lymphatic vasculature in human Alzheimer's dementia subjects.
    Goodman JR; Adham ZO; Woltjer RL; Lund AW; Iliff JJ
    Brain Behav Immun; 2018 Oct; 73():34-40. PubMed ID: 30055243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of the glymphatic/meningeal lymphatic system in Alzheimer's disease: insights into proteostasis and future directions.
    Yamada K; Iwatsubo T
    Cell Mol Life Sci; 2024 Apr; 81(1):192. PubMed ID: 38652179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides--implications for the mechanisms of Abeta clearance at the blood-brain barrier.
    Kuhnke D; Jedlitschky G; Grube M; Krohn M; Jucker M; Mosyagin I; Cascorbi I; Walker LC; Kroemer HK; Warzok RW; Vogelgesang S
    Brain Pathol; 2007 Oct; 17(4):347-53. PubMed ID: 17610523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance systems in the brain-implications for Alzheimer disease.
    Tarasoff-Conway JM; Carare RO; Osorio RS; Glodzik L; Butler T; Fieremans E; Axel L; Rusinek H; Nicholson C; Zlokovic BV; Frangione B; Blennow K; Ménard J; Zetterberg H; Wisniewski T; de Leon MJ
    Nat Rev Neurol; 2015 Aug; 11(8):457-70. PubMed ID: 26195256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation.
    Goulay R; Mena Romo L; Hol EM; Dijkhuizen RM
    Transl Stroke Res; 2020 Aug; 11(4):601-614. PubMed ID: 31776837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clearance of amyloid-β peptide across the choroid plexus in Alzheimer's disease.
    Alvira-Botero X; Carro EM
    Curr Aging Sci; 2010 Dec; 3(3):219-29. PubMed ID: 20735345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
    Wang YJ; Zhou HD; Zhou XF
    Drug Discov Today; 2006 Oct; 11(19-20):931-8. PubMed ID: 16997144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
    Chai AB; Leung GKF; Callaghan R; Gelissen IC
    FEBS J; 2020 Feb; 287(4):612-625. PubMed ID: 31750987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.